[Translation] A randomized, double-blind, placebo-controlled, dose-escalating Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of GPN00884 eye drops after single and multiple doses in healthy adult subjects
主要目的:评价GPN00884滴眼液在健康受试者中单次及多次给药后的安全性和耐受性。
次要目的:评价GPN00884滴眼液在健康受试者中单次及多次给药后的药代动力学(PK)特征。
[Translation] Primary objective: To evaluate the safety and tolerability of GPN00884 eye drops after single and multiple administrations in healthy subjects.
Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of GPN00884 eye drops after single and multiple administrations in healthy subjects.